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Transcriptional regulationr of essential functions for life. The development of such a complex organ relies
on ﬁnely regulated gene expression proﬁles which change over time in the development and determine the
phenotype and function of the liver. We used high-density oligonucleotide microarrays to study the gene
expression and transcription regulation at 14 time points across the C57/B6 mouse liver development, which
include E11.5 (embryonic day 11.5), E12.5, E13.5, E14.5, E15.5, E16.5, E17.5, E18.5, Day0 (the day of birth),
Day3, Day7, Day14, Day21, and normal adult liver. With these data, we made a comprehensive analysis on
gene expression patterns, functional preferences and transcriptional regulations during the liver develop-
ment. A group of uncharacterized genes which might be involved in the fetal hematopoiesis were detected.
© 2008 Elsevier Inc. All rights reserved.Background
The liver is one of the largest organs in the body and performs a
number of complex functions essential to life. Functions of the liver
range from converting glucose to glycogen, producing bile acids, to
forming plasma proteins and ﬁltering harmful substances from the
blood.
In mouse, liver ontogeny begins around E9 (embryonic day 9). At
E10.5 to E12.5, liver becomes a major site of fetal hematopoiesis [1].
Around E14.5, both hepatocytes and bile-duct epithelial cells develop
from the bipotential hepatoblast [1]. As these hepatoblasts gradually
become mature hepatocytes the main function of liver switches from
hematopoiesis to metabolism [1,2]. During liver development, gene
expression proﬁles change over time and determine the phenotypes
and functions of liver [3]. Elucidating molecular regulations in this
developmental process is important for understanding liver functionsed at MOE Key Laboratory of
/Department of Automation,
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l rights reserved.and also useful for exploring liver diseases. High-throughput gene
expression proﬁling techniques are well suited to reveal the expres-
sion changes in the developmental process.
We used high-density oligonucleotide microarrays to investigate
gene expression proﬁles and studied the transcriptional regulation in
mouse liver development. The gene expression data in this study were
sampled from fetal mouse liver tissue at E11.5, E12.5, E13.5, E14.5,
E15.5, E16.5, E17.5, E18.5, Day0 (the day of birth), Day3, Day7, Day14,
Day21, and from a normal adult liver tissue. Hierarchical clustering on
genes whose expressions changed by more than 1.5-fold during liver
development uncovered two groups of genes with distinct temporal
expression patterns. Genes in the ﬁrst group have high expression
mainly in the late stage of liver development and genes in the other
group are mostly activated in the early stage. GO biological function
analyses on the elevated and inhibited genes at each time point reveal
that in early embryo development, cell-cycle-related genes are highly
expressed; around the birth, defence-related genes are activated; and
liver-function-related TFs and genes are highly activated in the later
stage of development. Transcriptional regulation which controls the
gene expression in a tissue-speciﬁc and quantitative manner is a
major regulatory mechanism in embryonic developmental processes.
In order to identify transcriptional mechanisms involved in these
development stages, a computational approach was used to identify
the regulatory motifs that associated with the elevated and inhibited
236 T. Li et al. / Genomics 93 (2009) 235–242gene expression at each time point. With these identiﬁed TFs,
regulatory networks during mouse liver development were
constructed.
Results and discussion
Differential expression pattern in mouse liver development
Embryonic liver development goes through progressive series of
steps starting from the gastrula stage of embryogenesis [2]. Transcrip-
tional activities of genes are expected to be enhanced or inhibited to
regulate the abundance of gene products responsible for their
concerted functions during development. Transcription proﬁles at
different time points provide us novel insights into groups of genes
important to mouse liver development. To ﬁlter genes which do not
show signiﬁcant change in expression during liver development, we
select genes with expression values at any time point at least higher
than 1.5-fold or lower than 1/1.5-fold compared to the average (the
mean expression value of all 14 time points) for further analyses. This
gives 8640 genes in total, the list of which can be found in
Supplementary Table S1. To verify the microarray proﬁling, semi-
quantitative Reverse Transcription PCR (RT-PCR) is performed to
analyze the expression of four genes, alpha-fetoprotein (Afp), glucose-
6-phosphatase (G6pc), tyrosine aminotransferase (Tat), and albumin
(Alb) in different stages of mouse liver development. Semi-quantita-
tive RT-PCR results show that the expression of Afp starts in early fetal
liver (at least from E11.5) and nearly can't be detected in adult liver.
The expression of G6pc and Tat start in late fetal liver (E17.5). The
expression of Alb ranges from E11.5 to adult liver, which covers all
developmental stages of mouse liver. Expression proﬁles got by
microarray and Semi-quantitative RT-PCR are shown in Supplemen-
tary Fig. S1. From the ﬁgure we can ﬁnd that these two expression
proﬁles accordwith each other verywell. They are also very consistent
with current knowledge on these genes, suggesting that our
microarray data are appropriate for further transcriptomic analysis.
With these expression data, we can look into how some genes known
to be involved in liver development such as Hnf4a, Nfkb1, Cebpa, Xbp1
and Foxa1 are regulated temporally and involved in the function
switch from fetal to postnatal liver development (Supplementary
Fig. S2). The scientiﬁc community who is interested in liver de-
velopment and function can also ﬁnd the developmental expression
patterns of their interested genes from this work (Supplementary
Table S1).
To overview gene expression proﬁles across mouse liver develop-
ment, two-dimensional hierarchical clustering analysis is performed
on 8640 selected genes (Fig. 1A) by Cluster 3.0 [4] and visualized by
TreeView 1.60 (Michael Eisen, Stanford University. http://rana.lbl.gov/
EisenSoftware.htm). Expression values are adjusted by log transform
and mean center genes before clustering. The clustering result (Fig. 1A)
on the time dimension shows that all time points remain in their
original order. It is reasonable, since the development is a gradually
changed process and neighbouring time points have similar expression
snapshots. The ﬁrst bifurcating hierarchy of the cluster divides 14 time
points into two developmental stages, the embryonic and the postnatal
stage, delineated by the dividing point between E17.5 and E18.5. It
would be natural to expect that time points before and after birth
(around E18.5 and Day0) should be separated into two clades. But the
clustering result indicates that the expression proﬁle of E18.5 is more
similar to those of time points after birth. It was reported that
premature mice by caesarean section could not live if their gestational
ages were less than 19 days [5]. While caesarean birth mice can survive
and their weight handicaps in organs can be overcome in postnatal days
[6]. Results here may provide transcription-level explanation to this
anatomic observation.
The sample dendrogram is further divided into two sub-stages
(Stages I and II) corresponding to transiting from E14.5 to E15.5. Weobserved that expression levels of each gene at the ﬁrst sub-stage are
more homogenous compared with the second sub-stage. Previous
experiments indicated that E14.5 is a transition point of mouse liver
development around which hepatocytes and bile-duct epithelial cells
occurs [1]. Consistent with this result, hierarchical clustering reveal
two sub-stages of time points during embryonic liver development.
Data points of the postnatal stage are also divided into two clusters
(Stages III and IV). Expression proﬁles of the stage IV (ranging from
Day7 to NL) exhibited less time-invariant property suggesting the liver
has become near to the maturation.
Genes in Fig. 1A are also clearly split into two distinctive groups.
The ﬁrst group (Group A) includes 3703 genes, majority of which
have high expression levels in the postnatal stage of liver develop-
ment. While the other group (Group B) includes 4937 genes, most of
which are activated in the embryonic stage. Opposite trends of these
two groups suggest their different functions. We searched over-
represented and under-represented GO terms for these two groups of
genes separately. Bonferroni corrected hypergeometric p-values are
calculated to determine signiﬁcant enriched/depleted terms in each
group compared to the whole set of genes on the microarray
(enriched/depleted categories are listed in Fig. 1B for group A and Fig.
1C for group B, with lengths of pink bars equal to minus log of
corrected p-values). We ﬁnd that liver-related functional terms (e.g.
lipid, cholesterol, fatty acid metabolism, and steroid biosynthesis) are
enriched in group A; while cell cycle related terms (e.g. replication,
transcription, mRNA processing and translation) are enriched in
group B.
Visual inspection of group A identiﬁed a small clade of genes with
consistently high expression level at the postnatal stage (the pink part
of gene dendrogram in Fig. 1A with 414 genes). GO analysis indicates
the enrichment of “blood coagulation” biological process term in these
414 genes (Bonferroni corrected p-value 5.66e−16, blue bars in Fig.
1B). Among those forty genes which are annotated with the term
“blood coagulation” within the whole set (Fig. 1D), twenty two of
them are included in the group A and seventeen are included in these
414 genes, which indicates the speciﬁc expression pattern of these
blood coagulation related genes during mouse liver development.
In group B, majority of genes start high expression values from
E11.5 and become inactivated from E15.5. But a small subgroup of
genes (blue part in the gene dendrogram of Fig. 1A) distinguishes
themselves with augmented expression from E12.5 to E17.5. This
small group is comprised of 861 genes. GO analysis shows that the
“heme biosynthetic process” and “porphyrin biosynthetic process”
terms are signiﬁcantly enriched in this group (Bonferroni corrected
p-values equal to 6.48e−07 and 8.29e−07 respectively, blue bars in
Fig. 1C), consistent with the hematopoiesis function in the early
stage of liver development. After a closer examination of enriched
genes, we found that eight of total eleven genes annotated with
“heme biosynthetic process” in GO are included in the 861-gene
clade of group B (Fig. 1E). Genes labelled both with “porphyrin
biosynthetic process” and “heme biosynthetic process” terms in
annotation ﬁle are all encompassed in the 861-gene clade, which
forms the major contribution to the enrichment of the related GO
terms. It has been learned that around E10.5 to E12.5, liver becomes
a major site of fetal hematopoiesis [1]. Accordingly, the expression
activities of these genes come to a climax from E12.5 to E17.5 and
then become to wane from E18.5 on. The turning point in gene
expression thus reveals a functional switch from hematopoiesis to
metabolism [1,2]. This ﬁnding also suggests that the uncharacterized
genes included in the 861-gene clade might be associated with the
fetal hematopoiesis.
The liver is an essential organ for mammals and hepatocellular
carcinoma is among the topmost common, deadly cancerworld-wide.
It is interesting to ﬁnd the relation between hepatocellular carcinoma
(HCC) and liver development. We compared microarray data in this
study to a published array proﬁling dataset with 49 pairs of HCCs and
Fig. 1. Differential expression pattern in mouse liver development. (A) Heatmap for the 8640 genes whose expression levels are changed by more than 1.5-fold to average. Each row
represents the expression level for one gene during development; and each column is a developmental time point. Total 8640 genes are aggregated into two groups with opposite
trends. Two small clades of genes (highlighted as pink and blue part in the gene dendrogram) are picked out for further analysis. (B) Over-represented and under-represented
biological functions of Group A relative to the whole gene set on microarray. Pink bars list enriched or repressed functions of all genes in group A; and blue bars are for genes in the
pink clade of group A (414 genes). The bar length corresponds to the negative log p-value (after Bonferroni correction). (C) Over-represented and under-represented biological
functions of Group B relative to the whole gene set on microarray. Pink bars list the enriched or repressed functions for all genes in group B, and blue bars are for genes in the blue
clade of group B (861 genes). (D) The expression heatmap for all forty genes annotated with the term “blood coagulation”. Seventeen genes of them included in the pink clade of
group A (ref. A) with similar expression proﬁle are highlighted in pink. (E) Eleven genes annotated with the term “heme biosynthetic process”. Eight of them included in the blue
clade of group B (ref. A) are highlighted in blue.
237T. Li et al. / Genomics 93 (2009) 235–242adjacent liver tissues [7] (GSE4024 in the GEO database). According to
the hierarchical clustering result of samples, we have divided mouse
liver development into four stages. Here we compare enhanced genes
in each of four stages with genes which have enhanced expression in
HCC tissues. At each stage, genes with expression level 1.5-fold above
the control (average expression value of all 14 time points) are
selected as enhanced genes. To determinate upregulated genes in HCC,
we selected genes with expression value 2-fold above in at least 2 HCC
samples than those in corresponding adjacent liver tissues. Mouse
orthologys of genes in HCC arrays are got by the Biomart tool inEnsembl. Thenwe tried to ﬁnd relations between the HCC and each of
four liver development stages respectively by Fisher's Exact Test
(Table S2). We found that the upregulated genes in HCC are enriched
in genes which are enhanced in liver developmental stage I (p-value
1.53e−4) and stage II (p-value 0.008), and depleted in liver develop-
mental stage IV (p-value 7.19e−9). These ﬁndings suggest that genes
related to embryonic, proliferating stage could play important roles in
hepatocarcinogenesis. The microarray proﬁling in this study would
also provide a usable resource for the scientiﬁc community who are
interested in liver cancer research.
238 T. Li et al. / Genomics 93 (2009) 235–242Function analysis of elevated and inhibited genes at each time point
In different stages of liver development, genes with stage-speciﬁc
functions are often enhanced or inhibited at corresponding phases.
Based on the hypothesis that developmental-stage-speciﬁc genes
should play more important roles at the corresponding stage, we look
for over-represented and under-represented functions of elevated
genes and inhibited genes at each time point to get the “function
proﬁle” of mouse liver development.
At each time point, genes with expression level 1.5-fold above the
mean expression level are selected as enhanced genes and genes withFig. 2. Function analysis of elevated and inhibited genes at each time point. (A) The functional
genes at each time point are listed in the table, with shade representing the signiﬁcance lev
regulated genes. Enriched (blue) and depleted (red) functions of inhibited genes at each time
negative log of corrected p-value).expression level 1/1.5-fold below the mean are selected as inhibited
genes. Numbers of selected genes for each time point are displayed in
the Supplementary Fig. S3. We used the hypergeometric distribution
to detect over-represented or under-represented functions of elevated
and inhibited genes at each time point. Enriched or repressed func-
tions for elevated genes at each time point are displayed in Fig. 2A and
that for inhibited genes are displayed in Fig. 2B.
In Fig. 2A, enriched functions of elevated genes are represented in
red color and repressed functions of elevated genes are represented in
blue color. While in Fig. 2B, enriched functions of inhibited genes are
represented in blue color and repressed functions of inhibited areproﬁle for up-regulated genes. Enriched (red) and depleted (blue) functions of activated
el (scaled by the negative log of corrected p-value). (B) The functional proﬁle for down-
point are listed in the table, with shade representing the signiﬁcance level (scaled by the
239T. Li et al. / Genomics 93 (2009) 235–242represented in red color. The depth of the color represents the over-
represented or under-represented signiﬁcance of that function. A
“function proﬁle” along the mouse liver development is constructed:
in early embryotic development, cell-cycle-related TFs and genes are
highly expressed; around the birth, the defence-related genes start to
be activated; and liver-function-related TFs and genes are mostly
found in the later stage of the development.
We further use hypergeometric distribution to detect KEGG
pathways whose genes are enriched in elevated genes at each time
point. Enriched pathways for elevated genes at each time point are
displayed in Supplementary Table S3. Analysis results for KEGG
pathways are very similar to those of GO functions: at the early
embryotic stage, genes involved in pathways like cell cycle and DNA
replication are enriched in elevated genes; at the late stage near to
maturation, genes in pathways like bile acid biosynthesis and fatty
acid metabolism are enriched in elevated genes.
Over-represented cis-regulatory elements for each time point
The organ formation requires precise coordination of tissue-
speciﬁc gene expressions which change over time. Transcriptional
regulation controlling the gene expression in a tissue-speciﬁc and
quantitative manner is a major regulatory mechanism in embryonic
developmental process. To sieve cis-regulatory elements responsible
for the transcriptional regulation at each time point in liver
development, we use a computational approach to identify over-
represented motifs in promoter regions of up-regulated or down-
regulated genes relative to those of genes in the background set. For
each time point, among genes selected by the 1.5-fold change, the 500
most activated or inhibited (respectively) genes are taken as the
representation of up-regulated or down-regulated genes. If numbers
of selected gene are less than 500, only genes passed the 1.5-fold
criterion are used. The background set is constructed by 1000 genes
randomly chosen from the genome. Promoter sequences are got from
UCSC mm8 (−1000 and +200 nt from the TSS). The Motifclass in
CREAD package [8] is used to ﬁnd enrichedmotifs in promoter regions
of selected genes. Motifclass ﬁnds themost over-representedmotifs in
a set of foreground promoters according to the enrichment of motifs in
the foreground set relative to a background promoter set. For each
time point, the most relatively enriched motifs are those with the
lowest reported relative error rates. The 10 most qualiﬁed motifs for
enhanced and inhibited genes at each time point are displayed in
Supplementary Table S4 and Table S5, respectively.
In the hierarchical clustering result, 14 time points are divided into
4 stages, assuming time points in the same stage with similar
expression snapshots may have similar underlying regulations. Motifs
found to be over-represented in every time point of a stage should be
more likely to be related with a common function (Table 1). E2f1, Mef2
and Evi1 are found to be enriched in all time points of stage I and E2f1
is a key cell cycle regulator. In stage IV, a well known important liver-
speciﬁc TF Hnf4a is found to be highly enriched.
Transcription regulation networks across mouse liver development
The gene expression is controlled through the combinatorial
action of multiple transcription factors that activate or repressTable 1
Motifs which are over-represented in all time points of a stage
Stage Over-represented motifs of
enhanced genes
Over-represented motifs of
inhibited genes
I E2f1, Mef2, Evi1 Hnf4a, Repin1, Nf1, Smad3, Tal1
II Sp1 Nf1
III Myog, Smad3 E2f1
IV Hnf4a, Smad3 E2f1, Nfy, Sp1transcription via binding to cis-regulatory elements of their target
genes, reconstruction of regulatory networks during mouse liver
development can help us to understand mechanisms that control
the liver ontogeny. For four stages across mouse liver development,
we have got a group of TFs (Table 1) whose binding sites are
consistently over-represented in promoter regions of enhanced or
repressed genes across all time points of a stage. We use the
Staden's method [9] to predict targets of these over-represented TFs
from the most activated or inhibited genes. With selected TFs and
their predicted targets as nodes, and regulatory relations as arrow
edges from TFs to targets, we can get snapshots of dynamic
regulatory networks during mouse liver development (Supplemen-
tary Table S6). To facilitate the visualization, the sub-network with
top 50 inhibited and enhanced genes is displayed with the program
Cytoscape 2.4. Regulatory relations in the network are not always
activated. They consistently change over time to achieve activated or
inhibited expression of relevant genes. Here four regulatory net-
works are displayed according to the expression of target genes in
each stage (Fig. 3). For each gene, we ﬁrst take the average of
expression values across a stage as the mean expression value of
that stage. Then each gene has four mean expression values
corresponding to four stages. With the mean of all 14 time points
as control, genes with expression values higher than 1.5-fold are
taken as enhanced at the corresponding stage (red nodes in Fig. 3);
genes with expression values less than 1.5-fold and greater then 2/
3-fold are taken as expressed (pink nodes in Fig. 3); and genes with
expression values less than 2/3-fold are taken as inhibited (blue
nodes in Fig. 3).
In Fig. 3, we can get that TFs in networks can be classiﬁed into two
groups. The ﬁrst group (including Sp1, E2F1, Mef2, Evi1 and Nfy) is
activated from stage I and then decreases along the development. In
this group, most target genes have inhibited expression from stage III.
E2f1 is a well known TF in cell cycle. The expression proﬁle of
E2f1decreases during mouse liver development (Fig. 4), which may
result in the decreased expression of E2f1 targets. The second group
includes Hnf4a, Smad3, Tal1, Repin1 and Nf1. Most of their targets
express from stage III and are highly enhanced at stage IV. Hnf4a is a
well known liver enriched TF which is known to play important roles
in liver development. The expression of Hnf4a is displayed in Fig. 4,
which is consistent with its functional needs.
Materials and methods
Staging and preparation of embryos
Mouse embryos at various stages of gestation were obtained by
mating random-bred C57/B6 animals. Noon of the following day of
vaginal plug appearance was considered to be embryonic day 0.5.
Fetal liver tissue from C57/B6 mice of E11.5 (n=12), E12.5 (n=9),
E13.5 (n=9), E14.5 (n=6), E15.5 (n=6), E16.5 (n=3), E17.5 (n=3),
E18.5 (n=3), the birth day (n=3), 3 days (n=3), 7 days (n=3), 14 days
(n=3) and 21 days (n=3) after birth, as well as liver from mature
mice, 18 weeks after birth (n=3), were prepared under the binocular
microscope and pooled. The C57/B6 mouse strains were bred and
maintained to obtain embryos at National Institute of Biological
Sciences (NIBS) at Beijing. All animal experiments in this study were
approved by the Institutional Animal Care and Use Committee
(IACUC) of NIBS.
RNA extraction
Total RNA was extracted using TRIZol reagent according to the
manufacturer's instruction from Invitrogen. The poly+(A) RNA from
total RNA was performed by using oligo (dT) following the protocol
(Qiagen). The nucleotide acid concentration and quantity was
assessed by agarose gel electrophoresis or Agilent 2100 Bioanalyzer.
Fig. 3. Regulatory networks across mouse liver development. Regulatory relations in the network are not always activated. Here four regulatory networks are displayed according to the expression of target genes in the corresponding stage.
With themean of all 14 time points as contrast, genes with expression values higher than 1.5-fold of contrast are taken as being enhanced at the corresponding stage (red nodes); genes with expression values less than 1.5-fold and greater then
2/3-fold are taken as expressed (pink nodes); and genes with expression values less than 2/3-fold are taken as inhibited (blue nodes). These networks reﬂect a switch of cell-cycle related TFs/targets to liver function related TFs/targets.
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Fig. 4. Expression proﬁles of E2f1 and Hnf4a across mouse liver development. For consistence with the four stages of regulatory network, the average expression value of time points
in each stage is taken as the expression value of the TF at the corresponding stage.
241T. Li et al. / Genomics 93 (2009) 235–242Semi-quantitative reverse transcription PCR
Reverse Transcription (RT) was performed in a 20 μl reaction
systemwhich contained 2 μg total RNA, 20 pmol oligo-dT, mixed up to
11 μl with DEPC-H2O and then incubated at 70 °C for 5min. After 5min
at 0 °C, 4 μl 5×buffer, 2 μl 0.1 M DTT, 2 μl dNTP (10 mM) and 1 μl
(200 U) SurperScript II reverse transcriptase (Life Technologies),
incubated at 42 °C for 2 h. In PCR, β-actin was used as a control to
estimate the quality of cDNA (forward primer: 5′-TCACCCACACTGTGC
CCATCTACGA-3′ and reverse primer: 5′-CAGCGGAACCGCTCATTGCC
AATGG-3′). To further avoid DNA contamination, all primers in this
study were designed to span at least one exon. Each PCR was
performed as follows: pre-denature at 94 °C, 5 min; denature at 94 °C,
annealing at 55 °C, extend at 72 °C, 40 s, respectively, and ﬁnally at
72 °C for 7min. The PCR products were observed by electrophoresis on
2% agarose gel.
Microarray hybridization
The pooled RNA sample were labelled and hybridized to
Mouse430 high-density oligonucleotide arrays (Affymetrix), which
contains 45,037 probe sets on a single array. Totally 25 microarrays
have been used in this experiment, and 11 of the 14 time points
have two technique repeat experiments. The average of two
technique repeats was taken as the expression value for the
corresponding time point. One ug of poly(A)+RNA was annealed to
oligo(dT) and transcribed using SurperScript II reverse transcriptase
(Invitrogen, Carlsbad, CA), Labelling, hybridization, washing and
signal scan on the microarrays were performed according to the
manufacturer's instructions. Primary image analysis of the arrays
was performed using GENECHIP 3.2 (Affymetrix, Santa Clara, CA),
and normalization was performed using RMA software with CDF ﬁle
annotated by Dai et al. [10].
The obtained microarray data were deposited to the GEO database
with the accession number GSE13149.
Annotated the GeneChip with updated deﬁnitions
The Affymetrix GeneChip is a commonly used microarray
platform for genome-wide expression study. We ﬁrst annotated
our data with the CDF ﬁle of Affymetrix, which got 45037 probe
sets corresponding to 25978 Refseq transcripts. It has been found
that with the updated genome assembly, deﬁnitions of many genes/
transcripts on the arrays are out-of-date when mapping the probes
to the new version of genome assembly [11]. To solve this problem,
Dai et al. [10] aligned the probes to different sources of genome data
to ﬁlter out problematic probes. For the Genechip Mouse430 which
used in this study, they found that 20.8% of all probe sets havemapped to unreliable public IDs, 10.2% have probes with multiple
genome hits and 7.8% include probes with no known target. We
reannotated original .CEL ﬁles with annotations generated by Dai et
al. (NCBIM36.46). A commonly used software RMA [12] was used for
probe annotations. After processing, we got 21561 probe sets
corresponding to 21561 Refseq transcripts, 20822 (96.6%) of which
overlap with Affymetrixs' deﬁnition (Fig. S4). Only the deﬁnition of
Dai et al. is used in the current study.
GO function analysis
GO (http://www.geneontology.org) is a widely used gene func-
tional categorization system. Three ontologies have been proposed,
which include biological process, molecular function, and cellular
component. The Gene Ontology ﬁle (version: 1.555, Date: 2007/11/22)
and the mouse annotation ﬁle (gene_association.mgi. Version 1.692.
Date: 11/16/2007) were downloaded from http://www.geneontology.
org. Hypergeometric distributions were used to detect over-repre-
sented or under-represented biological process terms in the studied
set comparing to the population set. Probabilities got by hypergeo-
metric distributions were corrected by Bonferroni correction for the
test on multiple GO functions. In order to decrease the number of GO
terms, we only considered biological process ontology terms at 4, 5
and 6 levels. Terms with Bonferroni corrected p-values less than 1e−6
were taken as signiﬁcant ones.
Promoter sequences
Promoter DNA sequenceswere got fromUCSCdatabase. Transcripts
with no transcription start site (TSS) annotation in UCSC were not
included in the cis-regulatory elements analysis. Each promoter
sequence is taken 1,000 bp upstream to 200 bp downstream from
the TSS.
Identifying enriched motifs
All the motifs were represented by the position weight matrix.
Known motifs were got from the vertebrate subset of TRANSFAC
(Version 9.3). Motifclass in CREAD package [8] was used to ﬁnd
overrepresented TFs of selected genes. Motifclass ﬁnds the most over-
representedmotifs in a set of promoters (foreground) according to the
enrichment of motifs in the foreground relative to a background
promoter set. To evaluate the enrichment of a motif M with length w,
the motif was ﬁrst scored at every w-length subsequence in each
promoter sequence S. The maximum score (max-score) in S was used
as the promoter score for M. Giving a threshold λ, the method
classiﬁes the promoter sequences S as belonging to the foreground if
max-score≥λ, or to the background otherwise. For all the promoter
242 T. Li et al. / Genomics 93 (2009) 235–242sequences in the foreground (FG) and background (BG), the sensitivity
of motif M is:
se M;λ; FGð Þ = j SaFG : max−socre M; Sð Þ  λf gj=jFGj;
and the speciﬁcity is:
sp M;λ;BGð Þ = j SaBG : max−socre M; Sð Þ < λf gj=jBGj;
The enrichment of motif M in FG is deﬁned as:
B M;λ; FG;BGð Þ = 1− se M;λ; FGð Þ + sp M;λ;BGð Þð Þ=2:
For each motif M, the minimal value of the above equation was
taken as the error rate of motif M in FG relative to BG. Then all the
motifs were ranked based on the error rates and the 10motifs with the
least error rates were selected. The relative error rates for these
selected motifs were signiﬁcantly lower (p<0.01) on these promoter
sets relative to random promoters. Motifs do not pass the p<0.01
criterion were removed.
Predicting target genes for the over-represented TFs
Target genes for the over-represented TFs were predicted by the
Staden's method [9]. Given a motif M, base composition f and a match
score S, the Staden'smethod can calculate the p-value of observing the
match score S, that is, the probability that a randomly selected site has
a score at least as high as S. The base composition f was calculated
from the candidate set of the corresponding stage. The math score S
was obtained by scanning the promoter sequences of each candidate
genewith the PositionWeight Matrix of M. Genes with p-values lower
than 1e−5 were selected as target genes.
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